Our Products

Focusing on the diabetes as the core therapeutic field, Wanbang Biopharma has established a core competitive advantage in R&D, production and sales in the field of "four high one anti" (hyperglycemia, hypertension, hyperlipidemia, hyperuricemia and anti-tumor).
DiabetesCardiovascularAntitumorMetabolism and Digestion
NephropathyBig HealthOther FieldsActive Pharmaceutical Ingredients


No.1 Domestic Market Share (IQVIA data)


New Development Projects


Products with Annual Sales Exceeding 100 Million RMB